However, the prevalence of higher ANA titers (1:160) was greater in GO patients, although the difference did not reach statistical significance (Fig. 1 b).
2
—
—
The sentences
In addition, CAS was lower in ANA-positive patients (Mann–Whitney U : 1.5; P = 0.077), who had a lower prevalence of patients with active GO (CAS ≥ 3 points) (34.9 vs 53.1%; OR 0.4, 95% CI from 0.2 to 1, P = 0.061), although differences were only nearly statistically significant.